EOLS Message Board Post 9930858 | Evolus Inc.
home / stock / eols / eols message board
DAIsf
(investorshub)
Posted on: Dec/13/2022 16:03:36
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170682400
AEON Biopharma goes public via SPAC merger with PMGM:
News, Short Squeeze, Breakout and More Instantly...
-
Evolus dermal filler, Evolysse™ Lift, met primary endpoint of non-inferiority and demonstrated superiority to Restylane-L at 6 months; Secondary endpoints for improvement in nasolabial fold severity showed statistically significant differences compared to Restylane-L at all measured timepo...
-
David Moatazedi, President and Chief Executive Officer of Evolus, is first medical aesthetics leader to be a speaker at WWD Beauty CEO Summit Evolus' flagship product, Jeuveau ® is the fastest growing aesthetic toxin in the U.S. for the last three years 1 Evolus...
-
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that its Chief Financial Officer, Sandra Beaver, has been awarded Outstanding CFO of a Public Company by the Orange County Business Journal. The awar...